Related references
Note: Only part of the references are listed.Mouse models for muscular dystrophies: an overview
Maaike van Putten et al.
DISEASE MODELS & MECHANISMS (2020)
Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy
A. Moretti et al.
NATURE MEDICINE (2020)
Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
Diane E. Frank et al.
NEUROLOGY (2020)
Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing
Yi-Li Min et al.
MOLECULAR THERAPY (2020)
A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic Dmd deletion exhibits progressive muscular dystrophy and early-onset cardiomyopathy
Tatianna Wai Ying Wong et al.
DISEASE MODELS & MECHANISMS (2020)
Muscle Eccentric Contractions Increase in Downhill and High-Grade Uphill Walking
Xiao Hu et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
CRISPResso2 provides accurate and rapid genome editing sequence analysis
Kendell Clement et al.
NATURE BIOTECHNOLOGY (2019)
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
Christopher E. Nelson et al.
NATURE MEDICINE (2019)
CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells
Yi-Li Min et al.
SCIENCE ADVANCES (2019)
CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene
Tatiana Egorova et al.
DISEASE MODELS & MECHANISMS (2019)
Time origin and structural analysis of the induced CRISPR/cas9 megabase-sized deletions and duplications involving the Cntn6 gene in mice
Inna E. Pristyazhnyuk et al.
SCIENTIFIC REPORTS (2019)
CRISPR Correction of Duchenne Muscular Dystrophy
Yi-Li Min et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Gene suppressing therapy for Pelizaeus-Merzbacher disease using artificial microRNA
Heng Li et al.
JCI INSIGHT (2019)
PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models
Hien Tran Zhao et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements
Michael Kosicki et al.
NATURE BIOTECHNOLOGY (2018)
Eteplirsen treatment for Duchenne muscular dystrophy Exon skipping and dystrophin production
Jay S. Charleston et al.
NEUROLOGY (2018)
Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing
Chengzu Long et al.
SCIENCE ADVANCES (2018)
Base editing: precision chemistry on the genome and transcriptome of living cells
Holly A. Rees et al.
NATURE REVIEWS GENETICS (2018)
Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism
Dwi U. Kemaladewi et al.
NATURE MEDICINE (2017)
Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
Leonela Amoasii et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome
Ha Youn Shin et al.
NATURE COMMUNICATIONS (2017)
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System
Annalisa Lattanzi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders
Dania Wojtal et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Chromosome engineering in zygotes with CRISPR/Cas9
Katharina Boroviak et al.
GENESIS (2016)
Stem Cell-Mediated Exon Skipping of the Dystrophin Gene by the Bystander Effect
Mirella Meregalli et al.
CURRENT GENE THERAPY (2015)
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
Joe W. McGreevy et al.
DISEASE MODELS & MECHANISMS (2015)
The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
Catherine L. Bladen et al.
HUMAN MUTATION (2015)
Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides
Yehezkel Sztainberg et al.
NATURE (2015)
The first exon duplication mouse model of Duchenne muscular dystrophy: A tool for therapeutic development
Adeline Vulin et al.
NEUROMUSCULAR DISORDERS (2015)
Deletions, Inversions, Duplications: Engineering of Structural Variants using CRISPR/Cas in Mice
Katerina Kraft et al.
CELL REPORTS (2015)
Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia
William Duddy et al.
SKELETAL MUSCLE (2015)
Low dystrophin levels in heart can delay heart failure in mdx mice
Maaike van Putten et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice
Nicolas Wein et al.
NATURE MEDICINE (2014)
Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
Kane L. Greer et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice
Maaike van Putten et al.
FASEB JOURNAL (2013)
Gait Abnormalities and Progressive Myelin Degeneration in a New Murine Model of Pelizaeus-Merzbacher Disease with Tandem Genomic Duplication
Kristi Clark et al.
JOURNAL OF NEUROSCIENCE (2013)
Revertant Fibers in the mdx Murine Model of Duchenne Muscular Dystrophy: An Age- and Muscle-Related Reappraisal
Sarah R. Pigozzo et al.
PLOS ONE (2013)
The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology
Maaike van Putten et al.
PLOS ONE (2012)
Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy
Carol G. Au et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2011)
Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism
Guy Horev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice
Tao Yu et al.
BRAIN RESEARCH (2010)
Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics
Abdallah Fayssoil et al.
HEART FAILURE REVIEWS (2010)
Functional Efficacy of Dystrophin Expression from Plasmids Delivered to mdx Mice by Hydrodynamic Limb Vein Injection
Guofeng Zhang et al.
HUMAN GENE THERAPY (2010)
Personalized exon skipping strategies to address clustered non-deletion dystrophin mutations
Sarah Forrest et al.
NEUROMUSCULAR DISORDERS (2010)
Efficient Generation of Germ Line Transmitting Chimeras from C57BL/6N ES Cells by Aggregation with Outbred Host Embryos
Marina Gertsenstein et al.
PLOS ONE (2010)
Abnormal Behavior in a Chromosome-Engineered Mouse Model for Human 15q11-13 Duplication Seen in Autism
Jin Nakatani et al.
CELL (2009)
Mutational Spectrum of DMD Mutations in Dystrophinopathy Patients: Application of Modern Diagnostic Techniques to a Large Cohort
Kevin M. Flanigan et al.
HUMAN MUTATION (2009)
Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy
Annemieke Aartsma-Rus et al.
BMC MEDICAL GENETICS (2007)
Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities
Zhongyou Li et al.
HUMAN MOLECULAR GENETICS (2007)
Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2)
Katherina Walz et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings
JG Quinlan et al.
NEUROMUSCULAR DISORDERS (2004)
Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense
A Aartsma-Rus et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Mild overexpression of MeCP2 causes a progressive neurological disorder in mice
AL Collins et al.
HUMAN MOLECULAR GENETICS (2004)
A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia
C Arrondel et al.
KIDNEY INTERNATIONAL (2004)
Expression of dystrophin driven by the 1.35-kb MCK promoter ameliorates muscular dystrophy in fast, but not in slow muscles of transgenic Mdx mice
P Dunant et al.
MOLECULAR THERAPY (2003)
Electrocardiographic findings in mdx mice:: A cardiac phenotype of Duchenne muscular dystrophy
V Chu et al.
MUSCLE & NERVE (2002)
Share Paper
